In the same study, anagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor and a known anti-atherogenic agent [40,41], inhibited the accumulation of macrophages in the walls of aneurysms and also diminished the size of aneurysms in mice [39]. Here, DPP4 is linked to aneurysm.